NovoLog Mix 70/30 100 [iU]/mL
insulin aspart · INJECTION, SUSPENSION · Novo Nordisk
No Recall HistoryCurrently in Shortage
Plain English
NovoLog Mix 70/30 is a injection, suspension containing insulin aspart at 100 [iU]/mL, taken subcutaneous. Manufactured by Novo Nordisk.
Key Facts
- Brand Name
- NovoLog Mix 70/30
- Generic Name
- insulin aspart
- NDC Code (Product)
0169-3696- Manufacturer
- Novo Nordisk
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA021172
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 09/11/2002
Recall History
No Recall HistoryFrequently Asked Questions
What is NovoLog Mix 70/30 used for?
NovoLog Mix 70/30 contains insulin aspart. It is a injection, suspension taken subcutaneous. Consult your doctor for specific uses.
Is NovoLog Mix 70/30 a controlled substance?
NovoLog Mix 70/30 is not classified as a controlled substance by the DEA.
What is the generic name for NovoLog Mix 70/30?
The generic name for NovoLog Mix 70/30 is insulin aspart. There are 9 other brand versions of insulin aspart.
What is the NDC code for NovoLog Mix 70/30 100 [iU]/mL?
The NDC (National Drug Code) for NovoLog Mix 70/30 100 [iU]/mL is 0169-3696, listed by Novo Nordisk.
Other NovoLog Mix 70/30 Dosages
Other Insulin Brands
See all →- NOVOLOG100 [iU]/mL50090-1664
- KIRSTY100 [iU]/mL83257-007
- Insulin Aspart Protamine and Insulin Aspart Mix 70/30100 [iU]/mL70518-3236
- KIRSTY100 [iU]/mL83257-008
- Insulin Aspart100 [iU]/mL50090-4956
- MERILOG100 [iU]/mL0024-5927
- Insulin Aspart100 [iU]/mL73070-102
- Fiasp100 [iU]/mL0169-3201
- Fiasp100 [iU]/mL0169-3206
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)